Comparison
Rhodiola Rosea vs Kanna
Rhodiola Rosea
An Arctic adaptogen used for centuries in Siberian, Scandinavian, and Tibetan traditional medicine. The most-evidenced natural intervention for stress-induced mental fatigue and mild depression. Activating, not calming — take in the morning only, otherwise it disrupts sleep.
Kanna
Sceletium tortuosum — South African succulent. Acts as serotonin reuptake inhibitor and PDE4 inhibitor.
| Field | Rhodiola Rosea | Kanna |
|---|---|---|
| Category | adaptogen | adaptogen |
| Dose range | 200–400mg | 25–50mg |
| Half-life | 4h | — |
| Onset | — | — |
| Evidence | EVIDENCEA | EVIDENCEB |
| Safety | ●●●●● | ●●●○○ |
| Legal (US) | USOTC | USOTC |
| PubMed refs | 460 | 50 |
The comparison in plain English
Auto-generated from dataRhodiola Rosea and Kanna are both in the adaptogen category respectively. Rhodiola Rosea An Arctic adaptogen used for centuries in Siberian, Scandinavian, and Tibetan traditional medicine. Kanna Sceletium tortuosum — South African succulent.
Bottom line
Rhodiola Rosea (evidence A, safety 5/5) has a weaker evidence base than Kanna (evidence B, safety 3/5). Rhodiola Rosea has the slightly cleaner safety profile. For users new to either, the higher-evidence option is the safer first try.
Choose Rhodiola Rosea if
Rhodiola Rosea is the better fit when your goal aligns with its mechanism (Rosavins and salidroside (the two standardised active compounds) modulate the HPA axis cortisol response under acute stress) and the dose range (200–400mg) suits your protocol. Half-life is 4h.
Choose Kanna if
Kanna is the better fit when your goal aligns with its mechanism (Mesembrine and related alkaloids inhibit serotonin reuptake (similar to SSRI mechanism but at much lower potency) and PDE4 (similar to rolipram)) and the dose range (25–50mg) suits your protocol. Half-life is —h.